Clinical trial
Evaluation of the Effect of Tetravalent (A, C, Y, W-135) Meningococcal Conjugate Vaccine on Serogroup-Specific Carriage of Neisseria Meningitidis
NCT00119080 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Tetravalent (A, C, Y, W-135) Meningococcal Conjugate Vaccine on Serogroup-Specific Carriage of Neisseria Meningitidis
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2006
- Completion date
- May 31, 2007
- Enrollment
- 4,000
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.